ArticleOncotarget2017

STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.